Systematic study of the selenium fractionation in human plasma from a cancer prevention trial using HPLC hyphenated to ICP-MS and ESI-MS/MS
Sign Up to like & getrecommendations! Published in 2020 at "Analytical and Bioanalytical Chemistry"
DOI: 10.1007/s00216-020-02988-9
Abstract: This work represents the first systematic speciation study of selenium (Se) in plasma from subjects participating in a pilot study for a cancer prevention trial (PRECISE). This involved supplementation of elderly British and Danish individuals… read more here.
Keywords: plasma; cancer prevention; study; prevention trial ... See more keywords
Case-only analyses for identifying genotypes that modify the effect of finasteride in the Prostate Cancer Prevention Trial (PCPT): SWOG S9217.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.1551
Abstract: 1551Background: The Prostate Cancer Prevention Trial (PCPT) reported decreased risk of all prostate cancers but increased risk of high-grade prostate cancer in the finasteride arm. The aim of the present analysis was to identify genotypes… read more here.
Keywords: prostate; cancer prevention; prostate cancer; case ... See more keywords
Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials
Sign Up to like & getrecommendations! Published in 2023 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvad003
Abstract: Abstract Context Participants with stage 1 or 2 type 1 diabetes (T1D) qualify for prevention trials, but factors involved in screening for such trials are largely unknown. Objective To identify factors associated with screening for… read more here.
Keywords: prevention trials; prevention; prevention trial; type diabetes ... See more keywords